Welcome : Guest

Clearside Biomedical, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Clearside Biomedical, Inc., which is principally a Late-Stage Biopharmaceutical Company. Illustrated with 13 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66003
Price: $650
Company Type: Public
Pages: 14
Date: January 2017
Market Data Tables: 13

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Ophthalmic Drugs......2
Table 1: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......2
Table 2: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......3
Glaucoma......4
Table 3: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......4
Table 4: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......5
Table 5: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......6
Glaucoma Drugs......7
Table 6: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......7
Diabetic Macular Edema (DME)......8
Table 7: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......8
Table 8: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......9
Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF)......10
Table 9: Blindness Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Age-Related Macular Degeneration, Cataract, Glaucoma, and Others......10
Table 10: Wet Age-Related Macular Degeneration (AMD) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Avastin, Eylea, and Lucentis......11
AVA-101 Therapy......12
Table 11: Number of Patients for AVA-101 Therapy Drugs in the US (2015) - Percentage Market Share Breakdown by Volume for Avastin, Eylea, and Lucentis......12
Ophthalmology Drugs......13
Table 12: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......13
Table 13: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......14